| 1 |
34909649 | Reversal of TGF-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor. | 2021 |
1 |
| 2 |
32462038 | LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma. | 2020 |
1 |
| 3 |
28276928 | Plectin deficiency in liver cancer cells promotes cell migration and sensitivity to sorafenib treatment. | 2018 Jan 2 |
1 |
| 4 |
30272354 | Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling. | 2018 Dec |
1 |
| 5 |
30405889 | Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma. | 2018 Oct 9 |
1 |
| 6 |
29021381 | Activation of Focal Adhesion Kinase and Src Mediates Acquired Sorafenib Resistance in A549 Human Lung Adenocarcinoma Xenografts. | 2017 Dec |
1 |
| 7 |
27461522 | Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line. | 2016 Sep |
1 |
| 8 |
25447203 | Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma. | 2015 Feb 1 |
1 |
| 9 |
25862851 | Synergistic effect of sorafenib and vitamin K on suppression of hepatocellular carcinoma cell migration and metastasis. | 2015 Apr |
1 |
| 10 |
23724131 | Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection. | 2013 |
1 |